BACKGROUND: Reductions in glial density and enlargement of glial nuclei have been reported in the dorsolateral prefrontal cortex (dlPFC) in mood disorders. In alcohol dependence, often comorbid with depression, it is unclear whether there are changes in the density and size of glial cells in the dlPFC. METHODS: The packing density and size of Nissl-stained glial cell nuclei were analyzed postmortem in the cortical layers of the dlPFC from 21 control and 17 alcohol-dependent (Alc) subjects without Wernicke or Korsakoff syndromes. Eight Alc subjects had depressive symptoms. The density of glial cells was measured with a three-dimensional cell counting method, and the areal fraction of glial fibrillary acidic protein immunoreactivity (GFAP) was also determined. RESULTS: Glial density was reduced by 11-14% in layers V and VI and in all layers combined in the Alc group. The size of glial nuclei was decreased by 3.2% in Alc subjects. The Alc subjects with depressive symptoms showed the lowest values of density and size. There was no difference in GFAP immunoreactivity, although the lowest values were in the Alc group. CONCLUSIONS: Alcohol dependence is characterized by decreases in both density and size of glia in the dlPFC. Glial pathology may be more severe in Alc subjects with depressive symptoms.
BACKGROUND: Reductions in glial density and enlargement of glial nuclei have been reported in the dorsolateral prefrontal cortex (dlPFC) in mood disorders. In alcohol dependence, often comorbid with depression, it is unclear whether there are changes in the density and size of glial cells in the dlPFC. METHODS: The packing density and size of Nissl-stained glial cell nuclei were analyzed postmortem in the cortical layers of the dlPFC from 21 control and 17 alcohol-dependent (Alc) subjects without Wernicke or Korsakoff syndromes. Eight Alc subjects had depressive symptoms. The density of glial cells was measured with a three-dimensional cell counting method, and the areal fraction of glial fibrillary acidic protein immunoreactivity (GFAP) was also determined. RESULTS: Glial density was reduced by 11-14% in layers V and VI and in all layers combined in the Alc group. The size of glial nuclei was decreased by 3.2% in Alc subjects. The Alc subjects with depressive symptoms showed the lowest values of density and size. There was no difference in GFAP immunoreactivity, although the lowest values were in the Alc group. CONCLUSIONS:Alcohol dependence is characterized by decreases in both density and size of glia in the dlPFC. Glial pathology may be more severe in Alc subjects with depressive symptoms.
Authors: J J Miguel-Hidalgo; C Baucom; G Dilley; J C Overholser; H Y Meltzer; C A Stockmeier; G Rajkowska Journal: Biol Psychiatry Date: 2000-10-15 Impact factor: 13.382
Authors: P R Laming; H Kimelberg; S Robinson; A Salm; N Hawrylak; C Müller; B Roots; K Ng Journal: Neurosci Biobehav Rev Date: 2000-05 Impact factor: 8.989
Authors: Matthew Roy Williams; Thomas Hampton; Ronald K B Pearce; Steven Richard Hirsch; Olaf Ansorge; Maria Thom; Michael Maier Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-06-04 Impact factor: 5.270
Authors: Harry B M Uylings; Ernesto J Sanz-Arigita; Koos de Vos; Chris W Pool; Paul Evers; Grazyna Rajkowska Journal: Psychiatry Res Date: 2010-06-09 Impact factor: 3.222
Authors: José Javier Miguel-Hidalgo; Robert Waltzer; Angela A Whittom; Mark C Austin; Grazyna Rajkowska; Craig A Stockmeier Journal: J Affect Disord Date: 2010-06-26 Impact factor: 4.839
Authors: Jose J Miguel-Hidalgo; James C Overholser; Herbert Y Meltzer; Craig A Stockmeier; Grazyna Rajkowska Journal: Alcohol Clin Exp Res Date: 2006-11 Impact factor: 3.455
Authors: Moonnoh R Lee; Christina L Ruby; David J Hinton; Sun Choi; Chelsea A Adams; Na Young Kang; Doo-Sup Choi Journal: Neuropsychopharmacology Date: 2012-10-03 Impact factor: 7.853
Authors: José Javier Miguel-Hidalgo; Barbara A Wilson; Syed Hussain; Ashish Meshram; Grazyna Rajkowska; Craig A Stockmeier Journal: J Psychiatr Res Date: 2014-04-16 Impact factor: 4.791